首页 › 基金 › Atlas Venture Life Science Advisors, LLC › KRRO
Atlas Venture Life Science Advisors, LLC 对 KRRO 的持仓历史
KORRO BIO INC · 医疗保健
Atlas Venture Life Science Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 KRRO(KORRO BIO INC)773,260 股,市值约 US$7.7M,约占其申报组合的 1.21%,在其申报持仓中市值排名第 8 位。 Atlas Venture Life Science Advisors, LLC 最近 12 个申报季度中有 12 个季度披露了 KRRO 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Atlas Venture Life Science Advisors, LLC 对 KRRO 的持仓演变
Atlas Venture Life Science Advisors, LLC 于 Q4 2023 首次披露 KRRO 持仓:1,119,292 股(约 US$53.6M)。 该持仓在 Q1 2024 达到峰值 1,119,292 股,市值约 US$100.7M。 在 12 次申报中,Atlas Venture Life Science Advisors, LLC 1 次增持、2 次减持、8 次保持不变。 最近一期申报(Q3 2026)显示持股 773,260 股、市值约 US$7.7M,环比减持 -189,624 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 1.12M | $53.65M | 新进 |
| Q1 2024 | 1.12M | $100.74M | 持有 |
| Q2 2024 | 1.14M | $38.52M | 增持 |
| Q3 2024 | 1.14M | $38.00M | 持有 |
| Q4 2024 | 1.14M | $43.29M | 持有 |
| Q1 2025 | 1.14M | $19.80M | 持有 |
| Q2 2025 | 1.14M | $14.20M | 持有 |
| Q3 2025 | 1.14M | $54.46M | 持有 |
| Q4 2025 | 1.14M | $9.11M | 持有 |
| Q1 2026 | 1.14M | $12.87M | 持有 |
| Q2 2026 | 962.88K | $12.69M | 减持 |
| Q3 2026 | 773.26K | $7.66M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KRRO 与 13F 数据
KRRO(KORRO BIO INC)属于医疗保健行业。我们追踪的基金中还有 32 只申报持有 KRRO,申报仓位最大的包括:Lynx1 Capital Management LP (US$20.3M), NEA Management Company, LLC (US$17.1M), Venrock Adviser, LLC (US$13.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KRRO 的基金
- Lynx1 Capital Management LP 1.54M 股 · $20.27M · Q2 2026
- NEA Management Company, LLC 1.30M 股 · $17.11M · Q2 2026
- Venrock Adviser, LLC 1.01M 股 · $13.31M · Q2 2026
- TCG Crossover Management, LLC 416.30K 股 · $5.49M · Q2 2026
- Kalehua Capital Management LLC 473.60K 股 · $4.69M · Q3 2026
- 72 Investment Holdings, LLC 276.83K 股 · $3.65M · Q2 2026
更多关于 Atlas Venture Life Science Advisors, LLC
常见问题
How long has Atlas Venture Life Science Advisors, LLC held KRRO?
Atlas Venture Life Science Advisors, LLC has disclosed KRRO holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Atlas Venture Life Science Advisors, LLC's current position in KRRO?
As of Q3 2026, Atlas Venture Life Science Advisors, LLC holds 773.26K shares of KRRO (KORRO BIO INC), valued at $7.66M, representing 1.21% of its reported portfolio and ranking #8.
Has Atlas Venture Life Science Advisors, LLC been buying or selling KRRO?
In the latest 13F filing (Q3 2026), Atlas Venture Life Science Advisors, LLC reduced its position in KRRO. The position peaked in Q1 2024 at 1.12M shares.
Which other funds hold KRRO?
Other major institutional holders of KRRO include Lynx1 Capital Management LP, NEA Management Company, LLC, Venrock Adviser, LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.